全文获取类型
收费全文 | 3762篇 |
免费 | 605篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 126篇 |
妇产科学 | 70篇 |
基础医学 | 392篇 |
口腔科学 | 65篇 |
临床医学 | 717篇 |
内科学 | 694篇 |
皮肤病学 | 18篇 |
神经病学 | 473篇 |
特种医学 | 217篇 |
外科学 | 530篇 |
综合类 | 132篇 |
预防医学 | 363篇 |
眼科学 | 76篇 |
药学 | 361篇 |
中国医学 | 1篇 |
肿瘤学 | 142篇 |
出版年
2023年 | 58篇 |
2021年 | 63篇 |
2020年 | 77篇 |
2019年 | 62篇 |
2018年 | 103篇 |
2017年 | 131篇 |
2016年 | 122篇 |
2015年 | 135篇 |
2014年 | 140篇 |
2013年 | 231篇 |
2012年 | 153篇 |
2011年 | 144篇 |
2010年 | 135篇 |
2009年 | 174篇 |
2008年 | 147篇 |
2007年 | 135篇 |
2006年 | 118篇 |
2005年 | 118篇 |
2004年 | 105篇 |
2003年 | 105篇 |
2002年 | 94篇 |
2001年 | 93篇 |
2000年 | 97篇 |
1999年 | 94篇 |
1998年 | 53篇 |
1997年 | 39篇 |
1996年 | 52篇 |
1995年 | 43篇 |
1994年 | 32篇 |
1992年 | 88篇 |
1991年 | 79篇 |
1990年 | 68篇 |
1989年 | 71篇 |
1988年 | 67篇 |
1987年 | 78篇 |
1986年 | 70篇 |
1985年 | 82篇 |
1984年 | 59篇 |
1983年 | 41篇 |
1982年 | 31篇 |
1981年 | 33篇 |
1979年 | 43篇 |
1978年 | 40篇 |
1977年 | 36篇 |
1976年 | 31篇 |
1974年 | 40篇 |
1973年 | 40篇 |
1972年 | 30篇 |
1971年 | 39篇 |
1970年 | 34篇 |
排序方式: 共有4396条查询结果,搜索用时 15 毫秒
91.
92.
93.
Atrial fibrillation (AF) and heart failure (HF) commonly coexist, and their co-presence is associated with adverse outcomes
relating to thromboembolic events, HF progression, hospitalisation and death. Diastolic dysfunction (DD) is also frequently
present in patients with HF and is an independent predictor of hospitalisation and mortality. The presence of DD is a strong
predictor of incident AF in patients with HF. In this review, we provide mechanistic insight into pathophysiological processes
that frequently promote the occurrence of AF, HF and DD and outline the yin-yang relationship between AF, DD and HF. More
recently, invasive studies have also shown that asymptomatic paroxysmal atrial fibrillation (PAF) is a common phenomenon in
HF patients. We examine complex inter-relationships between PAF, HF and DD and speculate upon the possible clinical influence
of undiagnosed PAF in HF patients. 相似文献
94.
95.
Catheter ablation for persistent AF remains a challenge to the ablator as the disease is now outside the veins and cannot be tackled by pulmonary vein isolation alone. In this article we describe targeting complex fractionated atrial electrograms (CFAE) as a method to guide atrial substrate modification. 相似文献
96.
97.
Numerous clinical and research applications necessitate the ability to interface with peripheral nerve fibers to read and control relevant neural pathways. Visceral organ modulation and rehabilitative prosthesis are two areas which could benefit greatly from improved neural interfacing approaches. Therapeutic neural interfacing, or ‘bioelectronic medicine', has potential to affect a broad range of disorders given that all the major organs of the viscera are neurally innervated. However, a better understanding of the neural pathways that underlie function and a means to precisely interface with these fibers are required. Existing peripheral nerve interfaces, consisting primarily of electrode-based designs, are unsuited for highly specific(individual axon) communication and/or are invasive to the tissue. Our laboratory has explored an optogenetic approach by which optically sensitive reporters and actuators are targeted to specific cell(axon) types. The nature of such an approach is laid out in this short perspective, along with associated technologies and challenges. 相似文献
98.
Chengzhi Xie Holly Edwards J. Timothy Caldwell Guan Wang Jeffrey W. Taub Yubin Ge 《Molecular oncology》2015,9(2):409-421
Resistance to cytarabine and anthracycline‐based chemotherapy is a major cause of treatment failure for acute myeloid leukemia (AML) patients. Overexpression of Bcl‐2, Bcl‐xL, and/or Mcl‐1 has been associated with chemoresistance in AML cell lines and with poor clinical outcome of AML patients. Thus, inhibitors of anti‐apoptotic Bcl‐2 family proteins could be novel therapeutic agents. In this study, we investigated how clinically achievable concentrations of obatoclax, a pan‐Bcl‐2 inhibitor, potentiate the antileukemic activity of cytarabine in AML cells. MTT assays in AML cell lines and diagnostic blasts, as well as flow cytometry analyses in AML cell lines revealed synergistic antileukemic activity between cytarabine and obatoclax. Bax activation was detected in the combined, but not the individual, drug treatments. This was accompanied by significantly increased loss of mitochondrial membrane potential. Most importantly, in AML cells treated with the combination, enhanced early induction of DNA double‐strand breaks (DSBs) preceded a decrease of Mcl‐1 levels, nuclear translocation of Bcl‐2, Bcl‐xL, and Mcl‐1, and apoptosis. These results indicate that obatoclax enhances cytarabine‐induced apoptosis by enhancing DNA DSBs. This novel mechanism provides compelling evidence for the clinical use of BH3 mimetics in combination with DNA‐damaging agents in AML and possibly a broader range of malignancies. 相似文献
99.
100.
Daniel J. Stein Christian Salinas Saher Sabri Rose Onyeali Stephen Caldwell Zachary Henry 《Journal of vascular and interventional radiology : JVIR》2019,30(2):187-194